Navigation Links
SEK100 million ($12.83 million) for Karolinska Institutet's research into regenerative medicine
Date:6/22/2010

Karolinska Institutet has received a grant of SEK 100 million from the Knut and Alice Wallenberg Foundation for a regenerative medicine research centre the Wallenberg Institute for Regenerative Medicine (WIRM). This funding will give Karolinska Institutet a unique opportunity to concentrate on new and pioneering research, with a special focus on the blood system.

Regenerative research and stem-cell research are two areas in which revolutionary scientific advances have been made in recent years. The Swedish medical university Karolinska Institutet has long held a leading international position in these rapidly developing fields.

"The establishment of WIRM represents a unique opportunity to bring Karolinska Institutet's internationally leading basic research and clinical research together at a completely new centre. It will make it possible to address research issues we currently lack the resources to tackle," says Professor Urban Lendahl, Scientific Director of WIRM.

Growing knowledge of stem cells and regenerative medicine has opened up completely new avenues for the treatment of a number of diseases. The research at WIRM will cover a broad range of areas of therapy, but will focus in particular on the blood system and on the continued development of bone-marrow transplantation for those medical conditions and groups of patients that cannot currently be treated.

"It's tremendously pleasing and flattering that the bicentenary of Karolinska Institutet is being marked with this generous research grant from the Knut and Alice Wallenberg Foundation. The grant opens up fantastic opportunities for us to pursue pioneering research at the very highest international level in these extremely important areas," says Professor Harriet Wallberg-Henriksson, the President of Karolinska Institutet.

Thanks to the grant from the Wallenberg Foundation and the new research centre, Karolinska Institutet's infrastructure in the area is being strengthened through the establishment of advanced technical equipment and new experimental techniques. It is of the greatest strategic significance that the grant makes it possible to recruit key expertise, which will be crucially important in further advancing Sweden's position in this area.

"Having the opportunity to conduct research at Karolinska Institutet is a tremendously attractive prospect. The newly opened WIRM research centre will be well-placed to further strengthen the internationally leading position of Karolinska Institutet in stem-cell research and regenerative medicine," says Professor Sten Erik W. Jacobsen, a world-leading researcher at Oxford University in the biology and diseases of the blood system, who will now pursue part of his research in collaboration with investigators at Karolinska Institutet and WIRM.


'/>"/>

Contact: KI Press Office
pressinfo@ki.se
46-852-486-077
Karolinska Institutet
Source:Eurekalert

Related medicine news :

1. Kaiser Permanente Gives $5 Million to Childrens Healthcare of Atlanta
2. RadioShack Customers Donate $1.3 Million to LIVESTRONG
3. Michael J. Fox Foundation Awards $2.8 Million to Drive Development of Parkinsons Disease Biomarker Pipeline
4. Human Rights Denied: Obama Leaves 75 Million Children Behind
5. NVHR: Administrations 2011 Budget Proposal Shortchanges Five Million Americans Afflicted with Chronic Viral Hepatitis
6. State $200 Million Behind in Payments to Agencies Providing Care to Thousands of Older Illinoisans
7. Prominent Beverly Hills Law Firm Awarded $16.5 Million Medical Malpractice Jury Verdict
8. Esperanza Health Center Receives $6.5 Million in Stimulus Funds
9. Fitch, Standard & Poor's Upgrade Scripps Health to AA-; Scripps to Issue $220 Million in Hospital Revenue Bonds
10. millionants productions Launches and is “Making a Scene”
11. MAP International Provides $10 Million in Essential Medicines and Medical Supplies to Haiti Relief
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... ... On Tuesday, April 26, 2016 members of the HomeTown Health network, a ... Deal on SB 258, the “Rural Health Care Relief” Bill. , The bill, which ... to individuals and corporations which donate directly to a “rural hospital” in Georgia, and ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House ... their loans, more information about their loan terms and accounts, and more protections ... debt, including federal and private loans, has reached $1.3 trillion, with 43 million ...
(Date:4/29/2016)... ... April 29, 2016 , ... A ... born with severe congenital diaphragmatic hernia have better survival rates if surgery is ... hernia (CDH)—a condition where the diaphragm fails to form completely, letting abdominal organs ...
(Date:4/29/2016)... ... 2016 , ... Mobility Designed is redefining mobility with their patent pending ... Crutch evenly distributes body weight from the elbow to the forearm. In consumer ... than with other crutches. , Co-founders Max and Liliana Younger were inspired to design ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... Melanoma is the deadliest type of skin ... blame for the majority of skin cancer deaths. More than 10,000 people are expected to ... at diagnosis is 62, it is the one of the most commonly diagnosed cancers in ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016 Oramed Pharmaceuticals ... clinical-stage pharmaceutical company focused on the development of oral drug ... the upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... in New York . Nadav Kidron ... the conference. Presentation Details:   ...
(Date:4/28/2016)... New market research titled ... report that provides an overview of the Osteoarthritis,s ... identifying new targets and MOAs to produce first-in-class ... in this H1 2016 Osteoarthritis Pipeline report include ... Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, Inc., ...
(Date:4/27/2016)... , April 27, 2016   ... 42% Growth in Recurring Consumable Sales  Clinical ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of ... its sales for the first quarter ended March 31, ... the execution of its commercial strategy. First ...
Breaking Medicine Technology: